This opinion presents the safety evaluation of Butylated Hydroxyanisole (BHA) in cosmetic products. On the basis of its risk assessment, SCCS concludes that BHA is safe when used in leave-on and rinse-off cosmetic products at concentrations up to 0.07%. The committee further clarifies that this conclusion applies only to dermally applied products, and excludes oral care products as well as those that may result in inhalation exposure.
Original regulatory document
Request a Demo